干眼症代谢组学研究揭示血清雄激素可作为生物标志物
在英国TwinsUK人群代表队列2819名受试者中,采用非靶向代谢组学检测222种已知血清代谢物与干眼症(DED)的关联;DED患病率15.5%(n=436)。雄激素硫酸酯类代谢物降低与DED显著相关,其中硫酸雄酮(P=0.00030)和硫酸表雄酮(P=0.00036)达到代谢组全显著,且与干涩刺激症状的关联更强。
要点
- 硫酸雄酮(P=0.00030)和硫酸表雄酮(P=0.00036)降低与DED达代谢组全显著关联。
- 干涩刺激症状与雄激素类固醇代谢物降低的关联最强,5种雄激素均达代谢组全显著。
- 5种雄激素中硫酸表雄酮(P=0.0076)与2年临床诊断DED发病关联最强。
核心结论
- 无假设驱动的代谢组学方法发现血清雄激素降低与DED高度相关,为雄激素与眼表疾病及DED关联的研究增添了重要证据。
研究设计与样本
- 横断面关联研究,纳入英国TwinsUK人群代表队列2819名受试者,平均年龄57岁(范围17-82岁)。
- 检测222种已知血清代谢物与DED的关联,采用气相和液相色谱结合质谱对血浆样本行非靶向代谢组学分析(Metabolon公司,美国北卡罗来纳州达勒姆)。
- DED依据经验证的干眼综合征简短问卷(SQDES)定义:临床医生既往诊断DED,或「经常」或「持续」存在干涩和刺激症状。
- 采用线性混合效应模型分析,协变量包括年龄、BMI和性别,并校正多重检验。
主要发现
- SQDES定义的DED患病率为15.5%(n=436)。
- 硫酸雄酮降低(P=0.00030)和硫酸表雄酮降低(P=0.00036)与DED呈强且代谢组全显著的关联。
- 参与雄激素代谢的4-雄烯-3β,17β-二醇二硫酸酯1和2及硫酸脱氢表雄酮是222种代谢物中次强的关联,但未达代谢组全显著。
- 干涩和刺激症状(而非临床诊断)与雄激素类固醇代谢物降低的关联特别强,均达代谢组全显著:硫酸雄酮P=0.000000029、硫酸表雄酮P=0.0000040、4-雄烯-3β,17β-二醇二硫酸酯1 P=0.000016、4-雄烯-3β,17β-二醇二硫酸酯2 P=0.000064、硫酸脱氢表雄酮P=0.00011。
- 5种雄激素中硫酸表雄酮(P=0.0076)与2年临床诊断DED发病关联最强;另发现甘油磷酸胆碱降低与DED相关,但未达代谢组全显著。
关键数值与推荐
- DED定义:临床医生既往诊断DED,或「经常」或「持续」存在干涩和刺激症状(SQDES)。
- 代谢组全显著阈值对应硫酸雄酮P=0.00030、硫酸表雄酮P=0.00036。
- 症状相关分析中5种雄激素的P值分别为0.000000029、0.0000040、0.000016、0.000064和0.00011。
- 硫酸表雄酮与2年临床诊断DED发病关联的P=0.0076。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To test the association between serum metabolites and dry eye disease (DED) using a hypothesis-free metabolomics approach. DESIGN: Cross-sectional association study. PARTICIPANTS: A total of 2819 subjects from the population-representative TwinsUK cohort in the United Kingdom, with a mean age of 57 years (range, 17-82 years). METHODS: We tested associations between 222 known serum metabolites and DED. All subjects underwent nontargeted metabolomic analysis of plasma samples using gas and liquid chromatography in combination with mass spectrometry (Metabolon Inc., Durham, NC). Dry eye disease was defined from the validated Short Questionnaire for Dry Eye Syndrome (SQDES) as a previous diagnosis of DED by a clinician or "often" or "constant" symptoms of dryness and irritation. Analyses were performed with linear mixed effect models that included age, BMI, and sex as covariates, corrected for multiple testing. MAIN OUTCOME MEASURES: Primary outcome was DED as defined by the SQDES, and secondary outcomes were symptom score of DED and a clinical diagnosis of DED. RESULTS: Prevalence of DED as defined by the SQDES was 15.5% (n = 436). A strong and metabolome-wide significant association with DED was found with decreased levels of the metabolites androsterone sulfate (P = 0.00030) and epiandrosterone sulfate (P = 0.00036). Three other metabolites involved in androgen metabolism, 4-androsten-3beta,17beta-diol disulfate 1 and 2, and dehydroepiandrosterone sulfate, were the next most strongly associated of the 222 metabolites, but did not reach metabolome-wide significance. Dryness and irritation symptoms, as opposed to a clinical diagnosis, were particularly strongly associated with decreased androgen steroid metabolites, with all reaching metabolome-wide significance (androsterone sulfate, P = 0.000000029; epiandrosterone sulfate, P = 0.0000040; 4-androsten-3beta,17beta-diol disulfate 1, P = 0.000016; 4-androsten-3beta,17beta-diol disulfate 2, P = 0.000064; and dehydroepiandrosterone sulfate, P = 0.00011). Of these 5 androgens, epiandrosterone sulfate (P = 0.0076) was most associated with 2-year incidence of clinician-diagnosed DED. In addition, we found decreased glycerophosphocholines to be associated with DED, although not at metabolome-wide significance. CONCLUSIONS: This hypothesis-free metabolomic approach found decreased serum androgens to be highly associated with DED and adds important evidence to the growing body of research that links androgens to ocular surface disease and DED.
引用
- Vehof J, Hysi PG, Hammond CJ, et al. A Metabolome-Wide Study of Dry Eye Disease Reveals Serum Androgens as Biomarkers. Ophthalmology. 2017. PMID: 28139245. doi:10.1016/j.ophtha.2016.12.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。